Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct;12(10):1221-36.
doi: 10.1586/14787210.2014.956092.

Mechanisms of antibiotic resistance in enterococci

Affiliations
Review

Mechanisms of antibiotic resistance in enterococci

William R Miller et al. Expert Rev Anti Infect Ther. 2014 Oct.

Abstract

Multidrug-resistant (MDR) enterococci are important nosocomial pathogens and a growing clinical challenge. These organisms have developed resistance to virtually all antimicrobials currently used in clinical practice using a diverse number of genetic strategies. Due to this ability to recruit antibiotic resistance determinants, MDR enterococci display a wide repertoire of antibiotic resistance mechanisms including modification of drug targets, inactivation of therapeutic agents, overexpression of efflux pumps and a sophisticated cell envelope adaptive response that promotes survival in the human host and the nosocomial environment. MDR enterococci are well adapted to survive in the gastrointestinal tract and can become the dominant flora under antibiotic pressure, predisposing the severely ill and immunocompromised patient to invasive infections. A thorough understanding of the mechanisms underlying antibiotic resistance in enterococci is the first step for devising strategies to control the spread of these organisms and potentially establish novel therapeutic approaches.

Keywords: antimicrobial resistance; enterococcus; mechanisms of resistance; vancomycin-resistant enterococci.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Proposed mechanisms of daptomycin resistance in enterococci
Two main mechanisms have been postulated to mediate DAP resistance in enterococci. The first is diversion of the antibiotic from the septum (black arrow) by redistribution of cardiolipin microdomains away from the division plane at the septum level. This mechanism, characterized in Enterococcus faecalis only, is initially mediated by substitutions in the LiaFSR signaling system that controls cell envelope homeostasis. Changes in phospholipid synthesis enzymes (cardiolipin synthase and possibly a glycerol-phosphodiester phosphodiesterase) complete the resistance phenotype. The second mechanism, seen in E. faecium, is electrostatic repulsion of the positively charged daptomycin/calcium complex from the cell membrane. Several genes may be involved in this mechanism. DAP: Daptomycin.

Similar articles

Cited by

References

    1. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev. 1990;3:46–65. - PMC - PubMed
    1. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29:996–1011. - PubMed
    1. Williamson R, Calderwood SB, Moellering RC, et al. Studies on the mechanism of intrinsic resistance to beta-lactam antibiotics in group D streptococci. J Gen Microbiol. 1983;129:813–22. - PubMed
    1. Schatz A, Waksman S. Effect of streptomycin and other antibiotic substances upon Mycobacterium tuberculosis and related organisms. Proc Soc Exp Biol Med. 1944;57:244–8.
    1. Robbins WC, Tompsett R. Treatment of enterococcal endocarditis and bacteremia; results of combined therapy with penicillin and streptomycin. Am J Med. 1951;10:278–99. - PubMed

Publication types

MeSH terms

Substances